Health Watch -- Prostate research

 Health Watch is a Public Service of the Office of News and Publications and is intended to provide general information only and should not replace the advice of a medical professional. You should contact your physician if you have questions about any of these topics.

This week on Healthwatch we're talking about prostate disease and prostate cancer. While an enlarged prostate doesn't necessarily mean that a man will develop prostate cancer, it is a serious risk factor. Researchers at UT Southwestern Medical Center at Dallas have been at the forefront of research to find ways of treating enlarged prostate and preventing prostate cancer.

The drug, finasteride, is one of the most important treatments available for enlarged prostate. It's based on groundbreaking research conducted at UT Southwestern during the 1970's. At that time, scientists discovered that people with a particular enzyme deficiency didn't develop normal prostates or prostatic enlargement. Finasteride works by inhibiting the action of this enzyme, reducing the levels of the androgen most responsible for enlarged prostate and prostate cancer.


Nov. 2004

Health Watch is heard Monday through Friday nationwide on the "Stardust" format of ABC Satellite Radio. Call your local radio station and ask if they carry the program.